| Schedule of Unaudited Condensed Consolidated Financial Statements |
The impact of the restatement on the Company’s unaudited condensed consolidated financial statements is reflected in the following table:
|
|
|
As Previously Reported
|
|
Adjustment
|
|
As Restated
|
|
Condensed Consolidated Balance Sheet for the three months ended March 31, 2023 (unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Promissory Note – Related Party
|
|
$
|
257,014 |
|
|
$
|
1,882,986 |
|
|
$
|
2,140,000 |
|
|
Additional paid in capital
|
|
$
|
563,136 |
|
|
$
|
(563,136 |
)
|
|
$
|
—
|
|
|
Accumulated deficit
|
|
$
|
(15,207,806 |
)
|
|
$
|
(1,319,850 |
)
|
|
$
|
(16,527,656 |
)
|
|
Total Liabilities
|
|
$
|
15,881,107 |
|
|
$
|
1,882,986 |
|
|
$
|
17,764,093 |
|
|
Total Stockholders’ Equity (deficit)
|
|
$
|
(14,643,951 |
)
|
|
$
|
(1,882,986 |
)
|
|
$
|
(16,526,937 |
)
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidated Statement of Operations for the three months ended March 31, 2023 (unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in fair value of convertible promissory notes
|
|
$
|
1,319,850 |
|
|
$
|
(1,319,850 |
)
|
|
|
—
|
|
|
Total other income (expense)
|
|
$
|
909,732 |
|
|
$
|
(1,319,850 |
)
|
|
$
|
(410,118 |
)
|
|
Income before provision for income taxes
|
|
$
|
81,106 |
|
|
$
|
(1,319,850 |
)
|
|
$
|
(1,238,744 |
)
|
|
Net Income (loss)
|
|
$
|
(374,842 |
)
|
|
$
|
(1,319,850 |
)
|
|
$
|
(1,694,692 |
)
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| EPS: |
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted avg shares outstanding, Class A common stock |
|
|
21,188,697 |
|
|
|
— |
|
|
|
21,188,697 |
|
| Basic and diluted net loss per share, Class A common stock |
|
$ |
(0.01 |
) |
|
|
(0.05 |
) |
|
|
(0.06 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted avg shares outstanding, Class B common stock |
|
|
7,187,500 |
|
|
|
— |
|
|
|
7,187,500 |
|
| Basic and diluted net loss per share, Class B common stock |
|
$ |
(0.01 |
) |
|
|
(0.05 |
) |
|
|
(0.06 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidated Statement of Equity for the three months ended March 31, 2023 (unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds received in excess of initial fair value of Convertible Promissory Note
|
|
$
|
563,136 |
|
|
$
|
(563,136 |
)
|
|
$
|
—
|
|
|
Net Income (loss)
|
|
$
|
(374,842 |
)
|
|
$
|
(1,319,850 |
)
|
|
$
|
(1,694,692 |
)
|
|
Accretion for Class A common stock to redemption amount-APIC
|
|
$
|
(2,355,234 |
)
|
|
$
|
—
|
|
|
$
|
(2,355,234 |
)
|
|
Accumulated Deficit
|
|
$
|
(15,207,806 |
)
|
|
$
|
(1,319,850 |
)
|
|
$
|
(16,527,656 |
)
|
|
Total Stockholders Equity (deficit)
|
|
$
|
(14,643,951 |
)
|
|
$
|
(1,882,986 |
)
|
|
$
|
(16,526,937 |
)
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidated Statement of Cash Flows for the three months ended March 31, 2023 (unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income
|
|
$
|
(374,842 |
)
|
|
$
|
(1,319,850 |
)
|
|
$
|
(1,694,692 |
)
|
|
Change in fair value of convertible promissory note
|
|
$
|
(1,319,850 |
)
|
|
$
|
1,319,850 |
|
|
$
|
—
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Non Cash:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds received in excess of initial fair value of Convertible Promissory Note – Shares at initial borrowing
|
|
$
|
563,136 |
|
|
$
|
(563,136 |
)
|
|
$
|
—
|
|
|